SCHEMBL1823780

SCHEMBL1823780

CC(=O)C(O)c1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
ALDH1A1 P00352 4/20 0.46
LMNA P02545 3/20 0.45
HTT P42858 3/20 0.45
HSD11B1 P28845 1/20 0.41
HSD17B3 P37058 1/20 0.41
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPK1 P28482 2/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.39
EYA2 O00167 1/20 0.39
HTR6 P50406 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1822985 0.90 LMNA (0.51) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1823116 0.85 ALDH1A1 (0.46) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1824651 0.85 MAPT (0.48) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1827636 0.85 MAPT (0.48) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1827233 0.83 ALDH1A1 (0.50) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1827029 0.83 CA1 (0.34) HTTL3MBTL1NPSR1
SCHEMBL1822853 0.82 ALDH1A1 (0.46) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL1821434 0.81 MAPT (0.45) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL2834181 0.80 MAPT (0.49) MAPTALDH1A1LMNAHTTHSD11B1
SCHEMBL3721273 0.80 MAPT (0.49) MAPTALDH1A1LMNAHTTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 MAPT 4712/4885ALDH1A1 1099/4885LMNA 1802/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 MAPT 2237/4885ALDH1A1 1440/4885LMNA 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.